Incidence and disease burden of community-acquired pneumonia in southeastern China: data from integrated medical resources-Reference-Cited by-同舟云学术

Incidence and disease burden of community-acquired pneumonia in southeastern China: data from integrated medical resources

Published:2021-11-19 Issue: Volume: Page:1-8
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Jiang Ning¹,Li Ran¹,Bao Jing¹,Xie Yu¹,Ma Xiqian¹,He Yukun¹,Yu Yan¹,Chen Yusheng²³,Li Hongru²³,Zheng Yali⁴,Xue Qing⁵,Wu Jiangxi⁵,Xu Yu⁶,Fu Chuanxi⁷,Gao Zhancheng¹

Affiliation:

1. Department of Respiratory and Critical Care Medicine, Peking University People’s Hospital, Beijing, China

2. Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China

3. Department of Pulmonary and Critical Care Medicine, Fujian Provincial Hospital, Fuzhou, China

4. Department of Respiratory, Critical Care and Sleep Medicine, Xiamen University Xiang’an Hospital, Xiamen, Fujian, China

5. Department of Pulmonary and Critical Care Medicine, Ningde Municipal Hospital of Ningde Normal University, Ningde, Fujian, China

6. Department of Respiratory and Critical Care Medicine, Beijing Jishuitan Hospital, Beijing, China

7. School of Public Health, Institute of Infectious Disease and Vaccine, Zhejiang Chinese Medical University, Hangzhou, China

Funder

not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1996151

Reference31 articles.

1. WHO. The top 10 causes of death. 2020.

2. Ending preventable child deaths from pneumonia and diarrhoea by 2025. Development of the integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea

3. Incidence of community-acquired pneumonia in urban China: A national population-based study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of camrelizumab plus paclitaxel and carboplatin versus sintilimab plus gemcitabine and cisplatin or carboplatin for the first-line treatment of local advanced or metastatic squamous NSCLC in Chinese mainland;Frontiers in Pharmacology;2024-07-12

2. Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model;PharmacoEconomics;2024-07-03

3. Effects of Exclusive Breastfeeding Duration on Pneumonia Occurrence and Course in Infants Up to 6 Months of Age: A Case-Control Study;Journal of Community Health Nursing;2024-06-23

4. Cost-effectiveness analysis of bevacizumab for cerebral radiation necrosis treatment based on real-world utility value in China;Strahlentherapie und Onkologie;2024-06-03

5. Exploring the Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Unexplained Pulmonary Infection;International Journal of General Medicine;2024-05